Intel-Powered AI Solution can Reduce Diabetic Vision Loss by Hannah Joy on March 15, 2021 at 2:22 PM
The solution can identify diabetic retinopathy (DR), greatly reducing the screening burden on vitreoretinal surgeons. With Netra.AI, Sankara Eye Foundation and Leben Care have leveraged the power of Intel Xeon Scalable processors and built-in Intel Deep Learning (DL) Boost to accurately detect DR and enable timely treatment to effectively combat avoidable vision impairment and blindness in diabetic patients. Prakash Mallya, Vice President and Managing Director of Sales, Marketing and Communications Group, Intel India, said in a statement.
‘Netra.AI analyzes images from portable, technician-operated fundus camera devices, for immediate results of referable diabetic retinopathy (DR) grading via a cloud-based web portal.’